Department of Pulmonary Medicine, Christian Medical College, Vellore, India.
Department of Community Health, Christian Medical College, Vellore, India.
COPD. 2020 Apr;17(2):128-135. doi: 10.1080/15412555.2020.1723074. Epub 2020 Feb 5.
Rural population-based estimates of airflow obstruction based on spirometry are unavailable from southern India. This study assessed the prevalence of spirometry-defined airflow obstruction in Vellore, Tamil Nadu.A cross sectional survey was done in nine villages, among adults aged ≥30 years, where previous cardiovascular surveys had been conducted (1994, 2011). Population proportional to size sampling was used to select 20 clusters, with sampling from all streets proportional to the number of households. One person randomly selected per household was interviewed for symptoms and risk factors. A respiratory therapist performed pre and post bronchodilator spirometry on all, following American Thoracic Society criteria. Airflow obstruction was defined as pre-bronchodilator Forced Expiratory Volume 1 s/Forced Vital Capacity (FEV1/FVC) < Lower Limit of Normal (LLN, derived from local prediction equations) and compared to other criteria.Of 1015 participants, 787 completed technically acceptable spirometry. The prevalence of airflow obstruction was 9.0% (95% CI: 5.8%-9.6%, 71). Fixed obstruction (post bronchodilator FEV1/FVC < LLN) was 4.6% (95% CI: 3.1%-6.1%, 36), and 4.1% (95% CI: 2.7%-5.5%, 32) using post bronchodilator FEV1/FVC < 70%. The GOLD criteria missed 56% (40) of those with airflow obstruction, of which 87.5% were females. Although 63.4% with airflow obstruction had moderate to severe disease, 82.2% were not on treatment and only 48.9% reported symptoms in the previous year.This study estimates prevalence of airflow obstruction based on spirometry in rural southern India. Despite significant impairment on spirometry, majority were undiagnosed, and half did not report symptoms.
印度南部缺乏基于肺活量测定法的农村人群气流阻塞的估计数。本研究评估了泰米尔纳德邦维洛尔的肺活量测定法定义的气流阻塞的流行率。
在之前进行过心血管调查的 9 个村庄中,对年龄≥30 岁的成年人进行了横断面调查(1994 年、2011 年)。使用人口与大小成比例抽样选择 20 个聚类,从所有街道按家庭数量的比例抽样。对每个家庭随机选择一人进行症状和危险因素访谈。根据美国胸科学会的标准,对所有的呼吸治疗师在使用支气管扩张剂前后进行预支气管扩张剂肺活量测定。气流阻塞定义为预支气管扩张剂用力呼气量 1 秒/用力肺活量(FEV1/FVC)<正常值下限(LLN,源自本地预测方程),并与其他标准进行比较。
在 1015 名参与者中,787 名完成了技术上可接受的肺活量测定。气流阻塞的患病率为 9.0%(95%可信区间:5.8%-9.6%,71)。固定阻塞(支气管扩张后 FEV1/FVC<LLN)为 4.6%(95%可信区间:3.1%-6.1%,36),支气管扩张后 FEV1/FVC<70%为 4.1%(95%可信区间:2.7%-5.5%,32)。根据 GOLD 标准,有 56%(40 人)气流阻塞的患者被漏诊,其中 87.5%为女性。尽管有气流阻塞的患者中有 63.4%患有中重度疾病,但只有 82.2%接受了治疗,只有 48.9%在过去一年中报告有症状。
本研究估计了印度南部农村地区基于肺活量测定法的气流阻塞的流行率。尽管在肺活量测定法上存在明显的损害,但大多数患者未被诊断,且有一半患者未报告症状。